Freestone Capital Holdings’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $244K | Sell |
465
-73
| -14% | -$38.3K | 0.01% | 392 |
|
|
2025
Q1 | $341K | Sell |
538
-83
| -13% | -$52.6K | 0.01% | 333 |
|
|
2024
Q4 | $442K | Buy |
621
+9
| +1% | +$6.41K | 0.02% | 300 |
|
|
2024
Q3 | $643K | Buy |
612
+6
| +1% | +$6.31K | 0.02% | 256 |
|
|
2024
Q2 | $637K | Buy |
606
+14
| +2% | +$14.7K | 0.02% | 264 |
|
|
2024
Q1 | $570K | Buy |
+592
| New | +$570K | 0.02% | 283 |
|
|
2019
Q1 | – | Sell |
-967
| Closed | -$361K | – | 409 |
|
|
2018
Q4 | $361K | Buy |
+967
| New | +$361K | 0.02% | 321 |
|